Agalsidase beta 35mg powder for solution for infusion vials
previously Agalsidase beta 35mg powder for solution for injection vials
- SNOMED code
41758011000001108
previously407801001- Code valid from
- Named
- Active compound
- Agalsidase beta
- Preferred name basis
- rINN - Recommended International Non-proprietary
previously
rINN - Recommended International Non-proprietary - Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Agalsidase beta
— 35 mg
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Powder for solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Fabrazyme 35mg powder for concentrate for solution for infusion vials (Sanofi)
in short Fabrazyme 35mg pdr for concentrate for inf vials
previously Fabrazyme 35mg powder for solution for infusion vials
Fabrazyme 35mg powder for concentrate for solution for infusion vials
- SNOMED code
9524611000001103- Named
- Supplier
- Sanofi
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Fabrazyme 35mg powder for concentrate for solution for infusion vials (Sanofi) 1 vial9524711000001107 ref. pack | 💯 Available Legal category: POM | 5030045000173 | NHS Indicative Price £2,196 previously: £2,269 | • Personally Administered |
| — |
Reference packs
Agalsidase beta 35mg powder for solution for infusion vials 1 vial
- SNOMED code
9524511000001102- Quantity and unit
- 1 vial
- Packs